Terazosin
Product Images NDC 71610-546

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71610-546). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 10 mg (71610 0546 60)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

Figure 3 (Terazosin Hydrochloride Capsules 4)
This appears to be a table or graph with measurements taken over a time period of 30 months. The units are indicated as mL/sec. However, without additional information or context, it is impossible to determine the specific subject or purpose of the data.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.